Try our Advanced Search for more refined results
Intellectual Property
Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
Sign up for a 7-day FREE trial today!
Latest News in Intellectual Property
-
December 19, 2025
Google Says SerpApi Bypasses Security To Scrape IP
Google says data-scraping firm SerpApi circumvents its security measures protecting copyrighted content that appears in search results, alleging in a California federal lawsuit Friday that SerpApi steals content Google licenses from others "at an astonishing scale" and then resells it to its own customers.
-
December 19, 2025
In Reggaeton Case, Judge Asks If Beats Are Commonplace
A California federal judge questioned Friday whether music created by a pair of Jamaican artists is the foundation of thousands of reggaeton songs, asking one of their attorneys to address defense arguments that they are trying to own commonplace musical elements.
-
December 19, 2025
Samsung Wants $191.4M Patent Verdict Axed Or Cut To $1.7M
Samsung asked a Texas federal judge to wipe out a jury's $191.4 million verdict or grant it a new trial, arguing that no reasonable jury could find that its smartphones, computers and televisions infringe patents on organic light emitting diode technology owned by Pictiva Displays.
-
December 19, 2025
Rakoff Asks If Man Seeking 'Top Gun' Credit Had Copyright
U.S. District Judge Jed S. Rakoff on Friday asked an attorney for a man who claims that he wasn't credited for writing significant portions of the 2022 film "Top Gun: Maverick" why he shouldn't think the man knew he'd be infringing Paramount's copyrights given that he didn't have a contract to work on the movie.
-
December 19, 2025
AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims
A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly propped up blood disorder treatment Soliris, while preserving accusations that Alexion brought sham infringement allegations against would-be rivals.
Areas of Coverage
- LITIGATION
- Infringement suits over patents, copyrights, and trademarks
- Patent Trial and Appeal Board disputes
- Abbreviated New Drug Application (ANDA) litigation
- Section 301 cases
- Trade secrets disputes
- Licensing and royalty fights
- Right-of-publicity suits
- Antitrust disputes involving IP issues
- AGENCIES
- U.S. Patent and Trademark Office
- U.S. Copyright Office
- U.S. International Trade Commission
- World Intellectual Property Organization
- POLICY & REGULATION
- Patent reform legislation and related bills in Congress
- Efforts to streamline international intellectual property law
- ENFORCEMENT
- Piracy and counterfeiting actions
- International trade disputes involving IP issues
- PROFILES
- Personnel moves
- Profiles of IP practices
Readership
- Intellectual property lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the life sciences, technology, and other IP-focused industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals